Boycott, Kym M

6 records totalling $14,021,151.00 CAD, from official Government of Canada open data.

Embed this chart

1 record here has a warning sign

A warning sign is a reason to look closer, not proof that someone did something wrong. What are the warning signs?

Names on this page

The source files have no identifier for a recipient, and departments write the same name in different ways. This page puts together the records with these names. They differ only in letter case, accents, punctuation, "&" and "and", an article at the start, the legal form at the end (Inc., Ltd., LLP), or the French half of a name in two languages. How names are matched

By department

Records

BOYCOTT, Kym M 1 warning sign $5,000,000.00
Canadian Institutes of Health Research
FY 2013-2014
Canada

Enhanced CARE for RARE Genetic Diseases in Canada

Boycott, Kym M $3,345,430.00
Canadian Institutes of Health Research
FY 2017-2018
Canada

Beyond the Exome: Decoding the Next Frontier of the Rare Disease Genome

Boycott, Kym M $2,801,102.00
Canadian Institutes of Health Research
FY 2017-2018
Canada

Care4Rare Canada: Harnessing multi-omics to deliver innovative diagnostic care for rare genetic diseases in Canada (C4R-SOLVE)

Boycott, Kym M $1,400,000.00
Social Sciences and Humanities Research Council of Canada
Insight research
FY 2019-2020
Canada

The Canada Research Chairs Program (CRCP) aims to enable Canadian universities to foster research excellence and to enhance their role in the global, knowledge-based economy as world-class centres of...

Boycott, Kym M $1,374,619.00
Canadian Institutes of Health Research
Research in Priority Areas
FY 2024-2025
Canada

The specific objectives of this funding opportunity are to: • Generate high quality evidence required to optimize the RD diagnosis pathway in Canada; • Evaluate the health outcomes associated with...

Boycott, Kym M $100,000.00
Canadian Institutes of Health Research
Research in Priority Areas
FY 2020-2021
Canada

The objectives of this opportunity are to: • Put into practice proper ethical framework and technical infrastructure to enable genomic and phenotypic data access across borders; • Establish connecti...